Frontiers in Molecular Biosciences | Molecular Diagnostics and Therapeutics

Review

Published on 21 Sep 2023

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

in Molecular Diagnostics and Therapeutics

Xiaoping Li
Jiaye Zhong
Haoyu Li
Yinbiao Qiao
Xiaolei Mao
Huayan Fan
Yiwu Zhong
Saber Imani
Shusen Zheng
Jianhui Li

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1260883

4,941 views
8 citations

Original Research

Published on 19 Sep 2023

ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration

in Molecular Diagnostics and Therapeutics

Yong-Fei Tang
Bin Qiao
Ya-Bing Huang
Ming Wang

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1202524

2,803 views
2 citations

Review

Published on 15 Sep 2023

Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities

in Molecular Diagnostics and Therapeutics

Yang Xie
Yudi Wang
Wenjie Pei
Yue Chen

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1210347

2,337 views
2 citations

Review

Published on 12 Sep 2023

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy

in Molecular Diagnostics and Therapeutics

Elizabeth Robilotti
Nathalie C. Zeitouni
Marlana Orloff

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1178382

5,403 views
2 citations

Review

Published on 11 Sep 2023

A promising nucleic acid therapy drug: DNAzymes and its delivery system

in Molecular Diagnostics and Therapeutics

Lang Xiao
Yan Zhao
Meng Yang
Guangxin Luan
Ting Du
Shanshan Deng
Xu Jia

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1270101

5,581 views
8 citations

Mini Review

Published on 11 Sep 2023

SARS-CoV-2 infection as a potential risk factor for the development of cancer

in Molecular Diagnostics and Therapeutics

Natalia Ogarek
Paulina Oboza
Magdalena Olszanecka-Glinianowicz
Piotr Kocelak

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1260776

17,196 views
8 citations

Mini Review

Published on 11 Sep 2023

Real-time monitoring strategies for optimization of in vitro transcription and quality control of RNA

in Molecular Diagnostics and Therapeutics

Kyung Hyun Lee
Jaehwi Song
Seongcheol Kim
Seung Ryul Han
Seong-Wook Lee

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1229246

4,104 views
2 citations

Original Research

Published on 08 Sep 2023

A curated census of pathogenic and likely pathogenic UTR variants and evaluation of deep learning models for variant effect prediction

in Molecular Diagnostics and Therapeutics

Emma Bohn
Tammy T. Y. Lau
Omar Wagih
Tehmina Masud
Daniele Merico

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1257550

4,374 views
2 citations

Original Research

Published on 06 Sep 2023

Uniformly shaped harmonization combines human transcriptomic data from different platforms while retaining their biological properties and differential gene expression patterns

in Molecular Diagnostics and Therapeutics

Nicolas Borisov
Victor Tkachev
Alexander Simonov
Maxim Sorokin
Ella Kim
Denis Kuzmin
Betul Karademir-Yilmaz
Anton Buzdin

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1237129

2,555 views
5 citations

Original Research

Published on 01 Sep 2023

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease

in Molecular Diagnostics and Therapeutics

Emmanuel Israel Edache
Adamu Uzairu
Paul Andrew Mamza
Gideon Adamu Shallangwa
Fatma Hilal Yagin
Nagwan Abdel Samee
Noha F. Mahmoud

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1254230

4,489 views
5 citations

Original Research

Published on 01 Sep 2023

Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort

in Molecular Diagnostics and Therapeutics

Alexandra Louise Møller
Ninna Hahn Tougaard
Daniel Guldager Kring Rasmussen
Federica Genovese
Pernille Falberg Rønn
Tine Willum Hansen
Morten Asser Karsdal
Peter Rossing

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1229579

2,785 views
1 citation

Editorial

Published on 31 Aug 2023

Editorial: Molecular genetics of cutaneous melanoma: current status and future direction-volume II

in Molecular Diagnostics and Therapeutics

Zaida Garcia-Casado
Cristina Pellegrini
William C. Cho

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1273849

929 views

Editorial

Published on 31 Aug 2023

Editorial: Role of the SUMOylation in cancer regulation

in Molecular Diagnostics and Therapeutics

Xu Chen
Giovanni Smaldone
Pier Paolo Piccaluga
Yitao Qi

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1236230

2,234 views

Original Research

Published on 29 Aug 2023

Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma

in Molecular Diagnostics and Therapeutics

Shi-Zhou Deng
Xuechen Wu
Jiezhang Tang
Lin Dai
Bo Cheng

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1185832

1,966 views
4 citations

Editorial

Published on 29 Aug 2023

Editorial: Fibrotic tissue remodeling as a driver of disease pathogenesis

in Molecular Diagnostics and Therapeutics

Trayambak Basak
Sarika Saraswati

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1278388

1,274 views
1 citation

Editorial

Published on 29 Aug 2023

Editorial: Ferroptosis in cancer and Beyond—volume II

in Molecular Diagnostics and Therapeutics

Xin Wang
Jordan Lu
Guo Chen
Chaoyun Pan
Yanqing Liu

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1265127

1,438 views

Navigation group

Articles

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration

Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy

A promising nucleic acid therapy drug: DNAzymes and its delivery system

SARS-CoV-2 infection as a potential risk factor for the development of cancer

Real-time monitoring strategies for optimization of in vitro transcription and quality control of RNA

A curated census of pathogenic and likely pathogenic UTR variants and evaluation of deep learning models for variant effect prediction

Uniformly shaped harmonization combines human transcriptomic data from different platforms while retaining their biological properties and differential gene expression patterns

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease

Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort

Editorial: Molecular genetics of cutaneous melanoma: current status and future direction-volume II

Editorial: Role of the SUMOylation in cancer regulation

Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma

Editorial: Fibrotic tissue remodeling as a driver of disease pathogenesis

Editorial: Ferroptosis in cancer and Beyond—volume II